Cytiva News

  1. Cytiva's Fibro PrismA Technology Accelerates mAb Purification In LifeArc's Covid-19 Research 10/8/2020

    Cytiva, a global life sciences leader, made Fibro PrismA, the first product based on its new protein A fiber chromatography technology, available commercially earlier this year. The new technology is already accelerating research for customers and collaborators, such as LifeArc.

  2. Cytiva Launches Xcellerex Automated Perfusion System For More Efficient Manufacture Of Biotherapeutics 9/16/2020

    Cytiva, a global life sciences leader, is introducing an innovation to the market that supports the biotech industry’s move to continuous manufacturing. Called the Xcellerex Automated Perfusion System (APS), it simplifies processes and reduces risk when intensifying upstream operations.

  3. GE Healthcare Life Sciences Joins Children's Medical Research Institute To Optimize Gene Therapy Manufacturing 2/5/2020

    GE Healthcare Life Sciences and Children’s Medical Research Institute will jointly drive the development of new affinity ligands for the purification of adeno-associated viral (AAV) vectors used in gene therapies.

  4. GE Healthcare Life Sciences Plans New Manufacturing Facility In Switzerland 1/22/2020

    GE Healthcare Life Sciences is building a new 7,360 square meter facility in Grens, Switzerland, in the new Signy Park, for the manufacture of single use kits for the Sepax and Sefia cell processing systems. The facility will meet global regulatory requirements and is expected to be fully operational in 2022.

  5. GE Healthcare Life Sciences Allies With Pharmadule Morimatsu To Expand KUBio 12/5/2019

    The KUBio “factory in a box” is expanding to accelerate the accessibility of biotherapeutics on a global scale. Additional modular platforms will be introduced in 2020 allowing biopharma manufacturers to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.

  6. New KUBio Box For Viral Vectors Boosts Gene Therapy Manufacturing 10/28/2019

    GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity in the viral vector area.

  7. GE Healthcare Launches Super-Resolution Microscope 9/23/2019

    GE Healthcare launches a new microscope to support researchers and their ever-increasing need to see extreme details in cells, without having to choose whether speed, depth or clarity is more important. The DeltaVision OMX Flex super-resolution microscope is a highly stable, multichannel imaging platform optimized for structured illumination microscopy (SIM), and now includes EDGE confocal technology.

  8. Avalon GloboCare, GE Healthcare To Accelerate Bioproduction Of Cellular Medicines 7/24/2019

    Avalon GloboCare Corp., a leading clinical-stage global developer of cell-based technologies and therapeutics, has announced that they have established a strategic partnership with GE Healthcare.

  9. GE Healthcare And World Courier Collaborate To Drive Commercialization Of Cell And Gene Therapies 5/28/2019

    GE Healthcare and World Courier, a part of AmerisourceBergen, are combining their expertise in manufacturing and logistics to better patient access to cell and gene therapies. Together, they aim to create a seamless end-to-end supply chain that will enable the developers of these treatments to meet increasing global demand.

  10. Lonza To Establish Strategic Biomanufacturing Base In China Using GE Healthcare Solution 12/10/2018

    Lonza recently announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN).